Semaglutide Treatment in a Patient with Extreme Obesity and Massive Lymphedema: A Case Report.
極度肥胖及大規模淋巴水腫患者的 Semaglutide 治療:個案報告。
Obes Facts 2024-09-09
Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission.
嚴重肥胖患者住院期間使用胰高血糖素樣肽-一受體類似物治療的減重效果。
Cureus 2023-03-04
Sustained weight loss with semaglutide once weekly in patients without type 2 diabetes and post-bariatric treatment failure.
Semaglutide每週一次對非2型糖尿病患者及術後胃繞道治療失敗患者的持續減重效果。
Clin Obes 2023-09-11
Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery.
GLP1 受體激動劑治療對於在接受肥胖手術等待名單上的影響:Liraglutide 3.0 毫克和Semaglutide 1.0 毫克。
Biomedicines 2023-10-30
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery.
Semaglutide 2.4 毫克/週用於嚴重肥胖患者的減重,無論其是否有接受胃腸手術的病史。
Obesity (Silver Spring) 2024-01-02
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study.
Semaglutide的減重和心血管疾病風險結果:一項為期一年的多中心研究。
Int J Obes (Lond) 2024-04-29
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma.
Semaglutide 作為下丘腦肥胖的有前景治療:四名患有腦咽管瘤女性的六個月病例系列。
Pituitary 2024-08-01
Transformative weight loss with Dulaglutide: A case report of success in a challenging patient profile of an ex-sumo wrestler.
Dulaglutide 轉變性減重:一位前相撲選手挑戰性病患案例報告的成功。
Clin Case Rep 2024-09-02